Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Infection in 2012: mixed results of pre-exposure prophylaxis for HIV prevention.

Gray RH, Wawer MJ.

Nat Rev Urol. 2013 Feb;10(2):74-5. doi: 10.1038/nrurol.2012.259. Epub 2013 Jan 15. Review. No abstract available.

PMID:
23318361
2.

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.

Karim SS, Kashuba AD, Werner L, Karim QA.

Lancet. 2011 Jul 16;378(9787):279-81. doi: 10.1016/S0140-6736(11)60878-7. No abstract available.

3.

Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?

Molina JM, Pintado C, Gatey C, Ponscarme D, Charbonneau P, Loze B, Rozenbaum W, Delaugerre C.

BMC Med. 2013 Aug 23;11:186. doi: 10.1186/1741-7015-11-186. Review.

4.

Antiretrovirals for HIV prevention: translating promise into praxis.

Mayer KH.

Lancet. 2011 Jul 16;378(9787):206-8. doi: 10.1016/S0140-6736(11)61056-8. No abstract available.

PMID:
21763922
5.

Preexposure prophylaxis for HIV infection.

Steinbrook R.

JAMA. 2012 Sep 5;308(9):865-6. doi: 10.1001/jama.2012.9885. No abstract available.

PMID:
22820712
6.

Can further placebo-controlled trials of antiretroviral drugs to prevent sexual transmission of HIV be justified?

Kuhn L, Susser I, Stein Z.

Lancet. 2011 Jul 16;378(9787):285-7. doi: 10.1016/S0140-6736(11)60134-7. No abstract available.

PMID:
21763941
7.

Antiretroviral prophylaxis: a defining moment in HIV control.

Karim SS, Karim QA.

Lancet. 2011 Dec 17;378(9809):e23-5. doi: 10.1016/S0140-6736(11)61136-7. Epub 2011 Jul 21. No abstract available.

8.

[Post-exposure drug prevention of HIV infection].

Rave K, Jablonowski H, Ross B, Philipp T.

Med Klin (Munich). 1996 Sep 15;91(9):589-99. Review. German. No abstract available.

PMID:
8984318
9.

From START to finish: implications of the START study.

De Cock KM, El-Sadr WM.

Lancet Infect Dis. 2016 Jan;16(1):13-4. doi: 10.1016/S1473-3099(15)00477-6. No abstract available.

PMID:
26738819
10.

Pre-exposure prophylaxis and the promise of combination prevention approaches.

Buchbinder SP, Liu A.

AIDS Behav. 2011 Apr;15 Suppl 1:S72-9. doi: 10.1007/s10461-011-9894-1.

11.

Pre-exposure prophylaxis: increasing evidence for effectiveness but should the perspective return to test and treat?

Desai M.

Sex Transm Infect. 2012 Oct;88(6):475-6. No abstract available.

PMID:
23012494
12.

Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis.

Mayer K, Gazzard B, Zuniga JM, Amico KR, Anderson J, Azad Y, Cairns G, Dedes N, Duncombe C, Fidler SJ, Granich R, Horberg MA, McCormack S, Montaner JS, Rees H, Schackman B, Sow PS; International Association of Physicians in AIDS Care..

J Int Assoc Provid AIDS Care. 2013 May-Jun;12(3):208-16. doi: 10.1177/2325957413475839.

PMID:
23666450
13.

[HIV post-exposure prevention. Minutes are important--therefore PEP (postexposure prophylaxis) emergency set].

[No authors listed]

MMW Fortschr Med. 2000;142(3 Suppl):10. German. No abstract available.

PMID:
10893950
14.

Can antiretroviral therapy eliminate HIV transmission?

De Cock KM, Gilks CF, Lo YR, Guerma T.

Lancet. 2009 Jan 3;373(9657):7-9. doi: 10.1016/S0140-6736(08)61732-8. Epub 2008 Nov 27. No abstract available.

PMID:
19038440
15.

[Preexposure prophylaxis in the prevention of HIV infection].

Fernández-Montero JV, Soriano V.

Med Clin (Barc). 2011 Oct 15;137(10):446-8. doi: 10.1016/j.medcli.2011.04.017. Epub 2011 Jun 14. Spanish. No abstract available.

PMID:
21676414
16.

The future of HIV prevention in the United States.

Mermin J, Fenton KA.

JAMA. 2012 Jul 25;308(4):347-8. doi: 10.1001/jama.2012.8693. No abstract available.

PMID:
22820785
17.

HIV Pre-Exposure Prophylaxis - Is it just about pills?

Fernandez-Montero JV.

AIDS Rev. 2016 Oct-Dec;18(4):222.

PMID:
27918570
18.

Antiretroviral vaginal gel shows promise against HIV.

Baleta A.

Lancet. 2010 Jul 31;376(9738):320. No abstract available.

PMID:
20681062
19.

Pre-exposure prophylaxis effective.

[No authors listed]

AIDS Patient Care STDS. 2006 Sep;20(9):660. No abstract available.

PMID:
17036415
20.

Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.

Yacoub R, Nadkarni GN, Weikum D, Konstantinidis I, Boueilh A, Grant RM, Mugwanya KK, Baeten JM, Wyatt CM.

J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):e115-8. doi: 10.1097/QAI.0000000000000906. No abstract available.

Supplemental Content

Support Center